Cargando…

FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2

Type 2 idiopathic macular telangiectasia (MacTel) is a rare bilateral neurodegenerative disease characterized by alterations in the macular capillary network leading to central vision loss. The purpose of this study was to quantify disease-specific retinal fluorescence lifetime patterns in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solberg, Yasmin, Dysli, Chantal, Wolf, Sebastian, Zinkernagel, Martin S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2020
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924947/ https://www.ncbi.nlm.nih.gov/pubmed/30664123 http://dx.doi.org/10.1097/IAE.0000000000002411

Ejemplares similares

RETINAL FLECKS IN STARGARDT DISEASE REVEAL CHARACTERISTIC FLUORESCENCE LIFETIME TRANSITION OVER TIME
por: Solberg, Yasmin, et al.
Publicado: (2019)

FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY: Findings After Surgical Reattachment of Macula-Off Rhegmatogenous Retinal Detachment
por: Jaggi, Damian, et al.
Publicado: (2020)

FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY AS PREDICTOR OF LONG-TERM FUNCTIONAL OUTCOME IN MACULA-OFF RHEGMATOGENOUS RETINAL DETACHMENT
por: Jaggi, Damian, et al.
Publicado: (2022)

Fluorescence lifetime distribution in phakic and pseudophakic healthy eyes
por: Dysli, Chantal, et al.
Publicado: (2023)

FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY
por: Dysli, Chantal, et al.
Publicado: (2017)

Fluorescence lifetime imaging ophthalmoscopy
por: Dysli, Chantal, et al.
Publicado: (2017)

The Influence of Cataract on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO)
por: Lincke, Joel-Benjamin, et al.
Publicado: (2021)

Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy (Erratum)
por: Sauer, Lydia, et al.
Publicado: (2018)

IMPAIRMENTS IN CONE PIGMENT REGENERATION AND ABSOLUTE THRESHOLD IN MACULAR TELANGIECTASIA TYPE 2
por: Simunovic, Matthew P., et al.
Publicado: (2022)

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE
por: Kowalczuk, Laura, et al.
Publicado: (2017)

Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
por: Arendt, Petra, et al.
Publicado: (2019)

Management of Idiopathic Macular Telangiectasia Type 2
por: Khodabande, Alireza, et al.
Publicado: (2019)

Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study—Report No. 1
por: Kim, Young Ho, et al.
Publicado: (2020)

IMPAIRMENTS OF L-CONE/M-CONE AND S-CONE–MEDIATED COLOR DISCRIMINATION IN MACULAR TELANGIECTASIA TYPE II
por: Simunovic, Matthew P., et al.
Publicado: (2022)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Analysis of candidate genes for macular telangiectasia type 2
por: Parmalee, Nancy L., et al.
Publicado: (2010)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
por: Aydoğan, Tuğba, et al.
Publicado: (2016)

Optic Coherence Angiography Findings in Type-2 Macular Telangiectasia
por: Nalcı, Hilal, et al.
Publicado: (2017)

Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2
por: Tzaridis, Simone, et al.
Publicado: (2021)

Topographic Relationship between Telangiectasia and Cone Mosaic Disruption in Macular Telangiectasia Type 2
por: Zandi, Roya, et al.
Publicado: (2020)

Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2
por: Micevych, Paul S., et al.
Publicado: (2019)

Right-angled vessels in macular telangiectasia type 2
por: Tzaridis, Simone, et al.
Publicado: (2021)

Macular Telangiectasia Type 2: A Comprehensive Review
por: Kedarisetti, Kiran Chandra, et al.
Publicado: (2022)

Investigation of Retinal Morphology Alterations Using Spectral Domain Optical Coherence Tomography in a Mouse Model of Retinal Branch and Central Retinal Vein Occlusion
por: Ebneter, Andreas, et al.
Publicado: (2015)

Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment
por: Sauer, Lydia, et al.
Publicado: (2018)

Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
por: Kelkar, Aditya S, et al.
Publicado: (2021)

Choroidal vascularity index change in macular telangiectasia type 2
por: Chun, Heejeong, et al.
Publicado: (2022)

Hemorrhagic Bacillary Layer Detachment in Macular Telangiectasia Type 2
por: Ramtohul, Prithvi, et al.
Publicado: (2021)

Relative Ellipsoid Zone Reflectivity in Macular Telangiectasia Type 2
por: Goerdt, Lukas, et al.
Publicado: (2023)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
por: Chandran, Kiran, et al.
Publicado: (2023)

Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II
por: Enghelberg, Moises, et al.
Publicado: (2023)

CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS
por: Osaka, Rie, et al.
Publicado: (2018)

Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia
por: Cherepanoff, Svetlana, et al.
Publicado: (2012)

Structural-vascular-functional correlation in type 2 non-proliferative macular telangiectasia
por: Venkatesh, Ramesh, et al.
Publicado: (2022)

Unusual Presentation of Type 1 Idiopathic Macular Telangiectasia
por: Bentaleb Machkour, Zaïnab, et al.
Publicado: (2017)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2
por: Parmalee, Nancy L., et al.
Publicado: (2012)

Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2
por: Behrens, Alice, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ug1qpg362i4vutd8oafj9dj0mg